Invaluable Guidance: FDA’s Dean of Drug Reviews on “Enrichment Strategies”
This article was originally published in RPM Report
Executive Summary
FDA’s draft guidance on “Enrichment Strategies for Clinical Trials” fulfills an overdue goal from PDUFA IV. It also captures decades of wisdom from the agency’s senior drug review manager.